HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,762 | +100.5% | 46,121 | +89.2% | 0.02% | +125.0% |
| Q2 2023 | $879 | +4.1% | 24,374 | +10.3% | 0.01% | 0.0% |
| Q1 2023 | $844 | -48.3% | 22,104 | -23.0% | 0.01% | -52.9% |
| Q4 2022 | $1,633 | -99.8% | 28,690 | +10.0% | 0.02% | +41.7% |
| Q3 2022 | $1,031,000 | +53.0% | 26,090 | +54.4% | 0.01% | +71.4% |
| Q1 2022 | $674,000 | -8.4% | 16,900 | -7.7% | 0.01% | 0.0% |
| Q4 2021 | $736,000 | -1.1% | 18,300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $744,000 | -10.5% | 18,300 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $831,000 | +8.9% | 18,300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $763,000 | -11.6% | 18,300 | -9.4% | 0.01% | -11.1% |
| Q4 2020 | $863,000 | – | 20,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |